$110 Million is the total value of Fiera Capital (Europe) Ltd.'s 60 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 48.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIDU | Buy | BAIDU INCspon adr rep pfd | $23,529,000 | +16015.8% | 12,607 | +1100.7% | 21.36% | +19858.9% |
| ITUB | Buy | ITAU UNIBANCO HLDG SAspon adr rep pfd | $17,929,000 | +223.2% | 1,624,745 | +578.1% | 16.27% | +298.9% |
| JD | Buy | JD COM INCspon adr cl a | $7,046,000 | +1057.0% | 239,613 | +4031.3% | 6.40% | +1327.5% |
| ABEV | Buy | AMBEV SA NPVsponsored adr | $6,418,000 | +4014.1% | 1,111,291 | +113528.9% | 5.82% | +4965.2% |
| FMX | Buy | FOMENTO ECONOMICO MEXICANO Sspon adr units | $6,385,000 | +14411.4% | 68,108 | +4835.4% | 5.80% | +18009.4% |
| TAL | Buy | TAL ED GROUP | $5,619,000 | +2112.2% | 169,262 | +8279.3% | 5.10% | +2627.3% |
| LXFT | New | LUXOFT HLDG INC | $5,056,000 | – | 97,865 | +100.0% | 4.59% | – |
| BBD | Buy | BANCO BRADESCO S Asp adr pfd new | $4,721,000 | -2.1% | 510,089 | +148.1% | 4.28% | +20.9% |
| BAP | Sell | CREDICORP LTD | $4,227,000 | -28.4% | 30,073 | -55.2% | 3.84% | -11.6% |
| BRFS | Buy | BRF SA ADRsponsored adr | $3,971,000 | +1415.6% | 200,908 | +4438.2% | 3.60% | +1767.4% |
| TV | Buy | GRUPO TELEVISA SAspon adr rep ord | $3,932,000 | +2146.9% | 119,244 | +12478.5% | 3.57% | +2666.7% |
| BABA | New | ALIBABAsponsored adr | $3,634,000 | – | 43,588 | +100.0% | 3.30% | – |
| CBD | Buy | COMPANHIA BRASILEIRA DE DISTspn adr pfd cl a | $3,202,000 | +61.7% | 107,201 | +462.1% | 2.91% | +99.6% |
| UGP | Buy | ULTRAPAR PARTICIPACOES S A | $1,814,000 | +252.9% | 89,622 | +43.0% | 1.65% | +335.4% |
| CPA | Sell | COPA HOLDINGS SAcl a | $1,666,000 | +381.5% | 16,467 | -63.0% | 1.51% | +495.3% |
| CX | New | CEMEX SAB DE CVsponsored adr new | $1,656,000 | – | 175,005 | +100.0% | 1.50% | – |
| AVHOQ | Buy | AVIANCA HLDGS SAspon adr rep pfd | $1,408,000 | -94.3% | 124,523 | +15.3% | 1.28% | -92.9% |
| GRAM | Sell | GRANA Y MONTERO S A Asponsored adr | $1,150,000 | -53.9% | 152,023 | -36.7% | 1.04% | -43.0% |
| PFE | Buy | PFIZER INC | $647,000 | +352.4% | 18,533 | +1486.7% | 0.59% | +459.0% |
| MRK | Buy | MERCK & CO INC NEW | $424,000 | +46.7% | 7,362 | +43.9% | 0.38% | +81.6% |
| GILD | Sell | GILEAD SCIENCES INC | $423,000 | -78.2% | 4,309 | -97.2% | 0.38% | -73.1% |
| PBRA | Buy | PETROLEO BRASILEIRO SA PETROsp adr non vtg | $393,000 | -32.1% | 64,359 | +247.3% | 0.36% | -16.2% |
| Sell | GRUPO AVAL ACCIONES Y VALOREsponsored ads | $383,000 | -91.5% | 42,709 | -67.8% | 0.35% | -89.5% | |
| GGAL | New | GRUPO FINANCIERO GALICIA S Asp adr 10 sh b | $323,000 | – | 13,857 | +100.0% | 0.29% | – |
| BMA | New | BANCO MACRO SAspon adr b | $316,000 | – | 5,495 | +100.0% | 0.29% | – |
| CZZ | Buy | COSAN LTD | $305,000 | -93.0% | 47,798 | +75.3% | 0.28% | -91.4% |
| LCI | New | LANNET INC | $278,000 | – | 4,082 | +100.0% | 0.25% | – |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $272,000 | -84.1% | 2,020 | -97.7% | 0.25% | -80.4% |
| AMGN | Sell | AMGEN INC | $261,000 | +166.3% | 1,633 | -80.7% | 0.24% | +229.2% |
| AEGR | AEGERION PHARMA | $252,000 | +24.8% | 9,641 | 0.0% | 0.23% | +53.7% | |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $240,000 | +21.8% | 3,710 | +111.3% | 0.22% | +50.3% |
| VALE | New | VALE S Aadr | $217,000 | – | 38,411 | +100.0% | 0.20% | – |
| CVS | New | CVS HEALTH CORP | $214,000 | – | 2,068 | +100.0% | 0.19% | – |
| MDVN | Sell | MEDIVATION INC | $208,000 | -50.4% | 1,605 | -78.2% | 0.19% | -38.6% |
| IPXL | Buy | IMPAX LABORATORIES INC | $185,000 | +77.9% | 3,949 | +176.9% | 0.17% | +121.1% |
| ILMN | Sell | ILLUMINA INC | $176,000 | +93.4% | 948 | -66.9% | 0.16% | +138.8% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $155,000 | -14.8% | 341 | -78.3% | 0.14% | +5.2% |
| BDX | Buy | BECTON DICKINSON & CO | $151,000 | +88.8% | 1,050 | +344.9% | 0.14% | +132.2% |
| BSX | New | BOSTON SCIENTIFIC CORP | $136,000 | – | 7,675 | +100.0% | 0.12% | – |
| AMPH | Sell | AMPHASTAR PHARMACEUTICALS IN | $126,000 | -91.2% | 8,451 | -93.0% | 0.11% | -89.1% |
| ABT | Sell | ABBOTT LABORATORIES | $109,000 | -52.8% | 2,339 | -54.2% | 0.10% | -41.8% |
| CELG | Sell | CELGENE CORP | $105,000 | -97.2% | 908 | -99.1% | 0.10% | -96.6% |
| SYK | Sell | STRYKER CORP | $97,000 | -98.0% | 1,047 | -99.4% | 0.09% | -97.5% |
| EW | New | EDWARDS LIFESCIENCES CORP | $93,000 | – | 654 | +100.0% | 0.08% | – |
| BIIB | Sell | BIOGEN IDEC INC | $92,000 | +53.3% | 216 | -67.5% | 0.08% | +90.9% |
| CAH | New | CARDINAL HEALTH INC | $89,000 | – | 981 | +100.0% | 0.08% | – |
| INCY | Sell | INCYTE CORP | $79,000 | -64.7% | 857 | -82.4% | 0.07% | -56.4% |
| Q | Buy | QUINTILES TRANSNATIO HLDGS I | $65,000 | -53.6% | 973 | +185.3% | 0.06% | -42.7% |
| PCYC | Exit | QUINTILES TRANS | $0 | – | -973 | -100.0% | -0.04% | – |
| SLXP | Exit | STRYKER CORP | $0 | – | -1,047 | -100.0% | -0.07% | – |
| MYL | Exit | NANOSTRING TECH | $0 | – | -7,451 | -100.0% | -0.08% | – |
| MBT | Exit | MEDIVATION INC | $0 | – | -1,420 | -100.0% | -0.10% | – |
| NSTG | Exit | NPS PHARMACEUTICALS | $0 | – | -6,389 | -100.0% | -0.17% | – |
| GHDX | Exit | GILEAD SCIENCES INC | $0 | – | -3,035 | -100.0% | -0.21% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -5,332 | -100.0% | -0.26% | – |
| JNJ | Exit | LUXOFT HOLDING INC | $0 | – | -72,245 | -100.0% | -2.05% | – |
| P103PS | Exit | PETROBRAS PREF ADRspon adr pref | $0 | – | -426,250 | -100.0% | -2.39% | – |
| BMRN | Exit | BRADESCO PREF ADRspon adr pref | $0 | – | -515,289 | -100.0% | -5.09% | – |
| AGN | Exit | AMBEV SA NPV ADRsponsored adr | $0 | – | -1,150,999 | -100.0% | -5.52% | – |
| EEM | Exit | ITAU UNBANCO PRF ADRspon adr pref | $0 | – | -1,492,345 | -100.0% | -14.35% | – |
| PODD | Exit | ISHARE MSCI EMRG MKT | $0 | – | -546,201 | -100.0% | -15.77% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JD.COM ADR | 16 | Q1 2017 | 18.4% |
| GENOMIC HEALTH INC | 16 | Q1 2017 | 9.1% |
| PFIZER INC | 16 | Q1 2017 | 13.5% |
| FOMENTO ECONOMIC ADR | 16 | Q1 2017 | 5.1% |
| BRISTOL MYERS SQUIBB | 16 | Q1 2017 | 4.8% |
| BECTON DICKINSON | 15 | Q1 2017 | 21.4% |
| AMGEN INC | 14 | Q1 2017 | 9.3% |
| BRASIL FOODS ADR | 14 | Q1 2017 | 8.1% |
| VALE S A | 14 | Q1 2017 | 13.5% |
| PHARMACYCLICS INC | 14 | Q1 2017 | 0.8% |
View Fiera Capital (Europe) Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-13 |
| 13F-NT | 2023-11-02 |
| 13F-NT | 2023-08-08 |
| 13F-NT | 2023-05-09 |
| 13F-NT | 2023-02-13 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-09 |
| 13F-NT | 2022-05-16 |
| 13F-NT | 2022-02-11 |
| 13F-NT | 2021-11-12 |
View Fiera Capital (Europe) Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.